AI-powered Initiative Aims to Enhance Customer Engagement, Accelerate Commercial Execution and Support Long-Term Growth
Visit booth #112 in the Sparkle Ballroom at Fontainebleau Miami Beach for a live demonstration of Milo
ROSELAND, N.J., July 15, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a medical technology company developing proprietary precision drug delivery and Dynamic Pressure Sensing® technologies for medical and dental applications, today announced the launch of the first phase of its artificial intelligence ("AI") strategy with the introduction of Milo™, the Company's AI-enabled digital engagement platform, at the American Society of Pain and Neuroscience (ASPN) Annual Conference, taking place July 16–18, 2026, in Miami Beach, Florida.
Milo represents the first phase of Milestone's broader AI strategy and is designed to complement the Company's proprietary technologies through intelligent digital engagement, enhanced customer support and scalable commercial operations. The platform will be demonstrated as a pilot during ASPN 2026, where attendees will have the opportunity to experience Milo and provide feedback to support its continued development.
Initially, Milo is designed to answer common product questions, provide educational information, collect relevant customer information, assist with lead qualification and connect healthcare professionals with Milestone's sales, clinical and customer support teams.
"Artificial intelligence represents the next evolution of Milestone's innovation strategy," said Eric Hines, Chief Executive Officer of Milestone Scientific. "Healthcare professionals are incredibly busy and opportunities can be lost when we are unable to engage with prospects at the moment they express interest. Our initial objective with Milo is to provide immediate engagement, answer questions and make it easy to schedule product demonstrations at times that fit the schedules of potential customers, including evenings and weekends. We believe Milo will enhance the customer experience, accelerate lead conversion, improve commercial execution and support the continued growth of our Medical businesses."
Milestone's AI strategy is focused on four strategic initiatives:
Customer Engagement – Intelligent product education, lead qualification, customer support, scheduling and customer success.
Commercial Excellence – Sales and marketing automation, distributor support, CRM integration and commercial analytics.
Clinical Innovation – Evaluate AI-enabled software and data-driven capabilities that complement Milestone's proprietary technologies, subject to appropriate validation and regulatory requirements.
Connected MedTech Platform – Expand the integration of medical devices, software, data and AI to create a connected digital ecosystem supporting healthcare professionals throughout the customer lifecycle.